Glycosaminoglycans (GAGs) play a critical role in the binding and activation of growth factors in cell signal transduction required for biological development. A glycomics approach can be used to examine GAG content, composition, and structure in stem cells in order to characterize their general differentiation. Specifically, this method may be used to evaluate chondrogenic differentiations by profiling for the GAG content of the differentiated cells. Here, embryonic-like teratocarcinoma cells, NCCIT, a developmentally pluripotent cell line, were used as a model for establishing GAG glycomic methods, but will be easily transferrable to embryonic stem cell cultures.
Glycomics is the study of the structure and function of glycans, glycoconjugates including glycosphingolipids, glycoproteins, such as proteoglycans (PGs), and glycan-binding proteins. An understanding of the cellular glycome should explain some mysteries associated with these frequent and important posttranslational modifications (1) . The structural and functional glycomics of the glycosaminoglycan (GAG) chains (GAGome) of PGs from different tissues and cells are under intensive study in our laboratory (2) (3) (4) (5) . GAGs are linear, sulfated, heterogeneous polysaccharides consisting of various repeating disaccharide and are mainly located on both the external membrane of eukaryotic cells and within the extracellular matrix (6, 7) . There are four distinct families of GAGs: chondroitin/dermatan sulfate (CS/DS), heparin/heparan sulfate (HS), keratan sulfate (KS), and hyaluronan (HA). GAGs are involved in numerous biological activities and are important as molecular coreceptors, in cell-cell interactions, cell adhesion, cell migration, cell signaling, cell growth, and cell differentiation (8) (9) (10) .
Embryonic stem cells (ESCs) have enormous potential as a source of cells for cell replacement therapy and have been used as in vitro models to study specific aspects of early embryonic development (11, 12) . GAGs, particularly HS and CS, within stem cells play key roles in maintaining cell proliferation and differentiation (5) . Understanding the glycomics of ESCs should shed light on development, including the differentiation of chondrocytes from mesenchymal cells (13) (14) (15) . In our lab, we are using teratocarcinoma cells (NCCIT), a developmentally pluripotent cells, to offer a convenient model for ESCs. Methods for the elucidation of the GAGome within NCCIT cells, generally applicable for ESCs and their derivatives, such as chondrocytes, are described here for use in better understanding cell pluripotency and differentiation.
ESCs are able to differentiate into the mesenchymal cells that ultimately give rise to chondrocytes and endochondral ossification (13) (14) (15) . Cartilage is a specialized connective tissue that provides support for other tissues or prevents friction of the joints. The cartilage is comprised of chondrocytes that sparsely distribute in extracellular matrix filled with collagen fibrils and PGs. The fibrous structure of collagen provides support and maintains tissue shape, while PGs form gels and act as filler to facilitate compressibility and prevent friction as well as perform other critical signaling functions. The PGs in cartilage, such as decorin, biglycan, and aggrecan, are glycosylated with one or multiple GAG chains. In cartilage, the GAG components are mainly CS and KS and HA as well as smaller amounts of DS and HS. CS, the most abundant GAG in the cartilage, is composed of 4-O-sulfo, 6-O-sulfo, and 4,6-di-O-sulfo sequences (16, 17) . Research has shown that both the relative amounts of these sequences within CS and the length of CS chains change in aging and in diseases such as osteoarthritis (18) (19) (20) (21) . The GAG profile of differentiating ESCs may therefore help to elucidate whether or not chondrocytes have been formed, to what extent and may help to characterize the quality of the generated ESC-derived chondrocytes.
2. NCCIT cells (ATCC: CRL-2073), frozen and preserved in 95% culture medium and 5% DMSO, were from American 
Enzymatic Lyase Depolymerization of GAGs and Recovery of GAG Disaccharides
1. Unsaturated CS/DS disaccharides standards: Di-0S, UAGalNAc; di-4S, UA-GalNAc4S; di-6S, UA-GalNAc6S; di-UA2S, UA2S-GalNAc; di-diS B , UA2S-GalNAc4S; di-diS D , UA2S-GalNAc6S; di-diS E , UA-GalNAc4S6S; and di-triS, UA2S-GalNAc4S6S (Seikagaku Corporation).
2. Unsaturated heparin/HS disaccharides standards: di-0S, UAGlcNAc; di-NS, UA-GlcNS; di-6S, UA-GlcNAc6S; di-UA2S, UA2S-GlcNAc; di-UA2SNS, UA2S-GlcNS; di-NS6S, UA-GlcNS6S; di-UA2S6S, UA2S-GlcNAc6S; and di-triS, UA2S-GlcNS6S (Iduron). Disaccharide analysis is useful for assessing the structure of the GAGome in pluripotent cells such as teratocarcinoma cells and embryonic stem cells. Changes in the GAGome can then be correlated to alteration in the transcription levels for enzymes involved in GAG biosynthesis, PG core proteins, GAG-binding proteins such as growth factors, growth factor receptors, chemokines, and adhesion proteins. An improved knowledge of structural glycomics of GAGs should result in a better understanding
Disaccharide Analysis by LC-MS

Methods
of the relationship of the GAGome to the functional glycomics associated with stem cell differentiation.
The following protocol will explain how to characterize the GAGome of embryonic stem cells and their differentiated progeny using teratocarcinoma cells as a model. In brief, teratocarcinoma cells are grown to confluency and 10 7 cells are collected. The washed cell pellet is defatted, proteolyzed and GAGs are extracted into CHAPS/Urea. Spin column-based ion chromatography is then used to recover the CS and HS GAGs that are washed and then released in salt. After membrane-based desalting, the molecular weights of purified CS and HS GAGs are analyzed by PAGE. The CS and HS GAGs are then individually depolymerized to disaccharide mixtures using either chondroitinases or heparinases. The resulting disaccharide mixtures are analyzed by reversed-phase ion-pairing high performance liquid chromatography and detected by UV and MS.
Before performing the following steps, media should be taken out of the refrigerator and warmed to 37°C using a water bath. Make certain that the temperature never rises above 40°C. All steps performed in Subheading 3.1 were done in a laminar flow hood in a Biosafety Level 2 laboratory. The hood was sterilized with 70% (v/v) ethanol and exposed to UV light before use. All items taken into the hood were swabbed with 70% (v/v) ethanol.
Remove a vial of cells from the liquid nitrogen tank and thaw
quickly by swirling in the 37°C water bath. Make sure not to submerge the vial. Transfer the contents of the vial to a 15-mL centrifuge tube. With swirling add in a dropwise fashion 9 mL of warmed (37°C) NCCIT medium.
2. Centrifuge the cells at 250 × g for 5 min. Discard the supernatant and resuspend the pellet in 10 mL of prewarmed (37°C) NCCIT medium. Transfer the cells to a T25-cm 2 flask and place in the 37°C incubator.
3. Change culture medium when the color indicator in the medium changes from rosy pink to yellow (approximately every 2 days, change the media at least three times per week).
4. Take the cell culture flask out of the 37°C incubator and remove the medium carefully using sterile glass pipette. Avoid touching the side where cells are growing and add 10 mL of fresh medium to the flask before returning the cell culture flask to the incubator.
5. NCCIT cells should be passaged when they reach 80% of the confluency on the wall of cell culture flask (in our experience about 4 days) (Fig. 1 ). For passaging, take the cell culture flask out of the 37°C incubator. Using a microscope (20-fold magnification), estimate the confluency of cells growth on the flask wall. 1. Take the cell culture flask out of the incubator and remove the medium carefully using sterile glass pipette. Avoid touching the side where cells are growing and add 1 mL of cell detachment solution.
Preparation of Cells
2. Lay the flask down to let the solution completely contact with the layer of cells and wait for about 5 min. Add 9 mL of NCCIT medium. 10. Determine the percentile of cell viability and calculate the approximate total cell number in the medium. If viability is >50%, replate at higher density.
11. Repeat step 5. To the pellet, add 10 mL of PBS buffer.
12. Gently mix the cells and buffer using a pipette. Centrifuge at 1,000 × g for 3 min and rinse with PBS another two times, then collect the cell pellet after the last centrifugation minimum amount of PBS buffer (see Note 3).
Start with approximately 10
7
NCCIT cells prepared and counted using a hemocytometer as described in Subheading 3.1. Total GAG extraction as described previously (23) 3. Between the steps, leave the mixture to sediment. Remove the supernatant portion with a glass pipette before adding the new wash.
4. Perform a proteolysis step by incubating defatted cell pellets with actinase E proteolysis solution at 55°C overnight.
Recovery and Purification of GAGs
5. For GAGs extraction, add dry urea and dry CHAPS to the proteolyzed aqueous sample to obtain a final concentration of 2% (wt%) in CHAPS and 8 M in urea. Remove particles from the resulting solutions by either centrifuging at 4,000 × g or by passing the samples through a 0.22-m syringe filter.
6. To recover and purify GAG use a Vivapure Mini Q H spin column (see Note 5) . Wash and preequilibrate spin columns with 200 L denaturing solution by centrifuging at 2,000 × g. Load sample (approximately 0.5 mL) onto the wet spin column and run through the spin columns under 2,000 × g. Wash the spin column once with 200 L denaturing solution at 2,000 × g.
7.
Next, wash the spin column five times at 2,000 × g with 200 L prewash solution to remove nonspecific binding materials.
8. Elute HS and CS GAGs from column by washing three times at 2,000 × g with 50 L of collection solution.
9. Desalt GAGs with a Microcon® Centrifugal Filter Units YM-3 (3,000 MWCO) spin column (see Note 6) . To do so, load 100 L of NaOH to prewash the spin column and centrifuge at 12,000 × g.
10.
Rinse the column five times with 400 L of water to remove all the NaOH, centrifuging after each wash at 12,000 × g. Make sure the eluate is at pH 7 before proceeding further using pH strips.
11. Load GAG samples and centrifuge at 12,000 × g.
12.
Wash the membrane five times with 400 L of water to completely remove salts and other small molecules, centrifuging at 12,000 × g after each wash.
13. The GAGs are recovered from the top layer of the filtration membrane by inverting the membrane and centrifuging at 1,000 × g.
14.
Then rinse the surface of membrane three times, each time with 100 L of water centrifuging at 1,000 × g to obtain residual GAGs on membrane. Store the GAG-containing wash (approximately 350 L) at 4°C or lyophilize for future use.
1. Preparing the gel in a mini-gel electrophoresis system begins by washing all equipment and glass plates thoroughly with detergent before and rinsed extensively with distilled water before and after each use.
2. Prepare a 0.75 mm thick, 22% gel by mixing 6 mL of front gel buffer, 36 L of 10% (w/w) aqueous ammonium persulfate solution, and 6 L of TEMED, and mix rapidly with a needle.
Analysis of Intact GAGs
Preparing a Gel
3. Inject the gel into the sandwich glass plates by syringe, leaving some space for a stacking gel.
4. Cover the upper layer of the gel with water. The gel should polymerize within about 30 min depending on the room temperature. After the polymerization is set, carefully remove the water.
5. Prepare the stacking gel by mixing 2 mL of stacking gel buffer with 60 L of 10% (w/v) aqueous ammonium persulfate solution, and 2 L of TEMED, mixing rapidly with a needle. Using a syringe, inject the stacking gel to the top of separating gel. Insert a comb, carefully avoiding any air bubbles. The stacking gel should polymerize within about 30 min at room temperature.
6. Assemble the inner core of gel system. Once the stacking gel polymerization is done, carefully remove the comb and pour in upper buffer. Make certain there is no leakage on the assembled inner core. Add the resolving buffer to the lower chambers of the gel system. 3. Complete the assembly of the gel system and connect to a power supply. Gel electrophoresis is performed at 200 V for 90 min or until the phenol red reaches the bottom of the plate.
1. After electrophoresis is complete, carefully separate the gel from the glass plates.
2. Stain the gel with Alcian blue dye reagent for 30-60 min.
3. Completely destain the gel by shaking overnight in water.
4. Wrap the gel in clear plastic wrap and scan the gel with on a standard computer scanner (Fig. 2) . The scan can then be digitized using UN-Scan-it software.
5. A standard curve, the log of the molecular weight of each heparin oligosaccharide band (disaccharide 665, tetrasaccharide 1330, hexasaccharide 1995, etc.) as a function of migration distance, is plotted.
6. The pure oligosaccharide is used to provide a counting frame by identifying the size of the oligosaccharides in the heparin oligosaccharide mixture.
7. The average molecular weights of the GAGs isolated from the cells are calculated based on this standard curve (24). 3. In the current case, collect both the portion, which passes through the membrane, and the portion remaining above the membrane (the retentate). The CS/DS disaccharides have a molecular weight <3,000 and passing through the membrane should be collected in three washes, combined and lyophilized and used for further LC-MS analysis (Subheading 3.5.1).
Continue with the retentate with the following step.
4. GAGs in the retentate, remaining on the top of the filtration membrane, are next incubated with the heparinase I, II, and III enzyme mixture at 37°C for 10 h. The HS disaccharides have a molecular weight <3,000 and passing through the Microcon ® Centrifugal Filter Units YM-3 (3,000 MWCO) membrane should be collected in three washes, combined, Fig. 2 . PAGE analysis on GAGs isolated from NCCIT cells. Lane 1 shows heparin oligosaccharide with degree of polymerization of eight (dp8). Lane 2 shows heparin oligosaccharide standard where the degree of polymerization (dp) from four (tetrasaccharide) to 14 tetradecasaccharide is labeled. Lane 3 shows the isolated intact GAG mixture. PAGE analysis with Alcian blue staining confirmed that GAGs were present by a broad band of expected polydispersity. After digitizing the gels using UN-Scan-it software, the average MW of GAGs were calculated based on the heparin oligosaccharide standards. The average molecular weight of GAGs from NCCIT cells is 15.53 kDa. This method has been optimized by our laboratory and has been found to work well (2, 25, 26) . Two different eluent systems are required for the optimum resolution of the CS/DS and heparin/ HS disaccharides. 4. The column effluent should enter the UV detector followed by the source of the electrospray ionization mass spectrometer for continuous detection. and a source of temperature of 325°C to obtain maximum abundance of the ions in a full scan spectra (150-1,500 Da, ten full scans/s).
GAG Depolymerization
7. Use nitrogen as a drying (5 L/min) and nebulizing gas (20 p.s.i.). Detect with UV at 232 nm with simultaneous extracted ion chromatogram (EIC) detection (see Note 8) . The results of this analysis are presented in Fig. 3 and Table 1. 1. NCCIT cells were established by Shinichi Teshima (National Cancer Institute, Tokyo, Japan) in 1985 from a mediastinal mixed germ cell tumor (27) . This pluripotent stem cell line is capable of somatic and extraembryonic differentiation. The undifferentiated cells are equivalent to a stage intermediate between seminoma and embryonal carcinoma. They will differentiate in response to retinoic acid (28). HS/Hp: 0S, UA-GlcNAc; NS, UA-GlcNS; 6S, UA-GlcNAc6S; 2S, UA2S-GlcNAc; NS2S, UA2S-GlcNS; NS6S, UA-GlcNS6S; 2S6S, UA2S-GlcNAc6S; TriS, UA2S-GlcNS6S. CS/DS: 0S, UA-GalNAc; 2S, UA2S-GalNAc; 6S, UA-GalNAc6S; 4S, UA-GalNAc4S; Di-diS B , UA2S-GalNAc4S; Di-diS D , UA2S-GalNAc6S;
Notes
Di-diS E , UA-GalNAc4S6S; TriS, UA2S-GalNAc4S6S; n.d., not detected.
